BF Biosciences in talks to manufacture COVID-19 drug in Pakistan
Gilead Sciences had earlier said it was negotiating long-term voluntary licenses with several generic drugmakers in Pakistan to produce remdesivir for developing countries Gilead Sciences had earlier said it was negotiating long-term voluntary licenses with several generic drugmakers in Pakistan to produce remdesivir for developing countries
Post a Comment